Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens (Q70860091)
Jump to navigation
Jump to search
scientific article published on 01 January 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens |
scientific article published on 01 January 1996 |
Statements
Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens (English)
E H Choy
C Pitzalis
A Cauli
J A Bijl
A Schantz
J Woody
G H Kingsley